Under conditions of hypoxia, where p-ezrin, and at later time points, NHE1 protein levels are increased, these interactions appear to facilitate changes in PASMC phenotype that would promote vascular remodeling and the development of pulmonary hypertension. Here, SLC9A1 is linked to pulmonary arterial hypertension.